2024 – Consortium of Multiple Sclerosis Centers

Kathy Costello The Consortium of Multiple Sclerosis Centers (CMSC) Board of Governors is pleased to announce the appointment of [...]

New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis Data support frexalimab as a [...]

Not-for-profit celebrates past achievements and looks to the future POWELL, Ohio, February 29, 2024 (Newswire.com) - The Siegel Rare [...]

Consortium of Multiple Sclerosis Centers (CMSC) Best Practices Guideline on the Use of Neurofilament Biomarkers in MS Erratum: This [...]

I got an email recently from someone well up the chain of command at a multiple sclerosis (MS) patient advocacy organization. The purpose [...]

Yearly Archives: "2024"